The overall goal of our research is to develop new antibody-based medications to treat chronic and acute methamphetamine (METH) abuse.
Se-Ran Jun, Ph.D.
Horacio Gomez-Acevedo, Ph.D.
Intawat Nookaew, Ph.D.
My research focuses on the area of applied bioinformatics/computational biology and systems biology for biomedical research. I have developed novel advanced algorithms and frameworks to accelerate the utilization and mining for biological interpretation of omics data (genome, transcriptome, proteome and metabolome) for biomedical research translation (cancer, obesity, diabetes, autoimmune disease, metabolic dysfunction, etc.). In addition, […]
Donald Johann, Jr., M.S., M.D.
Galina V. Glazko, Ph.D.
David Ussery, Ph.D.
We are using ‘third generation sequencing technology’ (such as Oxford Nanopore flow cells) to do metagenomics of clinical isolates and environmental samples.
Mathias Brochhausen
Alexei G. Basnakian, M.D., Ph.D., D.Sc.
The lab studies the role of DNases in tissue injury and cell death.
Steve W. Barger, Ph.D.
My lab is focused on Alzheimer’s disease. Current research is examining the role of diabetes-related disruptions in glucose metabolism and the impact this has on brain function. Evidence indicates that both Alzheimer’s and diabetes involve processes connected to inflammation, which has been another of my longstanding areas of research.